Medical News

Surgery

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jaksch P et al. - A 12-month CMV prophylaxis with oral valganciclovir is effective in significantly reducing CMV viremia and CMV disease/syndrome in high-risk lung transplant recipients. In addition, a reduction in acute and recurrent rejection episodes was observed, possibly due to less CMV viremia and subsequent immunomodulatory effects.

Related Articles

Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09    Relevance Score: 84%

Today in Infectious Disease...keeping you current

Using antimicrobial solution for irrigation in appendicitis to lower surgical site infection rates
The American Journal of Surgery, 12/11/09

Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
Transplant Infectious Disease, 12/11/09

Prevention of lung ischemia–reperfusion injury by short hairpin RNA–mediated caspase-3 gene silencing
The Journal of Thoracic and Cardiovascular Surgery, 12/10/09

Today in Transplantation...keeping you current

Should we perform heart retransplantation in early graft failure
Transplant International, 12/11/09

Tetrandrine ameliorated reperfusion injury of small bowel transplantation
Journal of Pediatric Surgery, 12/11/09

Device Therapy and Cardiac Transplantation for End-Stage Heart Failure
Current Problems in Cardiology, 12/11/09